Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 41% ± 21% | |
lung | 13 studies | 30% ± 10% | |
peripheral blood | 12 studies | 27% ± 13% | |
eye | 9 studies | 39% ± 16% | |
heart | 5 studies | 31% ± 6% | |
liver | 5 studies | 37% ± 17% | |
intestine | 5 studies | 23% ± 9% | |
bone marrow | 4 studies | 32% ± 15% | |
adipose | 4 studies | 34% ± 11% | |
kidney | 4 studies | 24% ± 8% | |
placenta | 3 studies | 30% ± 17% | |
uterus | 3 studies | 31% ± 14% | |
breast | 3 studies | 25% ± 5% | |
skin | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 10232.66 | 459 / 459 | 100% | 52.06 | 1118 / 1118 |
esophagus | 100% | 9494.33 | 1445 / 1445 | 100% | 43.71 | 183 / 183 |
lung | 100% | 10313.42 | 578 / 578 | 100% | 37.63 | 1155 / 1155 |
ovary | 100% | 10484.87 | 180 / 180 | 100% | 34.46 | 430 / 430 |
prostate | 100% | 8901.13 | 245 / 245 | 100% | 41.12 | 502 / 502 |
stomach | 100% | 7202.20 | 359 / 359 | 100% | 35.36 | 286 / 286 |
brain | 100% | 11097.16 | 2640 / 2642 | 100% | 47.53 | 705 / 705 |
bladder | 100% | 10997.71 | 21 / 21 | 100% | 33.97 | 503 / 504 |
uterus | 100% | 10910.57 | 170 / 170 | 100% | 37.24 | 458 / 459 |
thymus | 100% | 9523.18 | 653 / 653 | 100% | 40.93 | 603 / 605 |
intestine | 100% | 10997.84 | 966 / 966 | 100% | 34.29 | 525 / 527 |
pancreas | 100% | 4461.81 | 328 / 328 | 99% | 34.30 | 177 / 178 |
kidney | 100% | 6861.27 | 89 / 89 | 99% | 34.90 | 888 / 901 |
liver | 100% | 3749.23 | 226 / 226 | 98% | 21.79 | 397 / 406 |
adrenal gland | 100% | 7404.63 | 258 / 258 | 97% | 31.37 | 224 / 230 |
skin | 100% | 9237.71 | 1808 / 1809 | 97% | 33.29 | 458 / 472 |
adipose | 100% | 10195.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12293.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.23 | 29 / 29 |
spleen | 100% | 9163.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.18 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.20 | 1 / 1 |
muscle | 100% | 5988.93 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 8201.93 | 911 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 5949.06 | 842 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 27.78 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0031571 | Biological process | mitotic G1 DNA damage checkpoint signaling |
GO_0010506 | Biological process | regulation of autophagy |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0032435 | Biological process | negative regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0006338 | Biological process | chromatin remodeling |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005681 | Cellular component | spliceosomal complex |
GO_0005634 | Cellular component | nucleus |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | WAC |
Protein name | WW domain containing adaptor with coiled-coil WW domain-containing adapter protein with coiled-coil |
Synonyms | KIAA1844 |
Description | FUNCTION: Acts as a linker between gene transcription and histone H2B monoubiquitination at 'Lys-120' (H2BK120ub1) . Interacts with the RNA polymerase II transcriptional machinery via its WW domain and with RNF20-RNF40 via its coiled coil region, thereby linking and regulating H2BK120ub1 and gene transcription . Regulates the cell-cycle checkpoint activation in response to DNA damage . Positive regulator of amino acid starvation-induced autophagy . Also acts as a negative regulator of basal autophagy . Positively regulates MTOR activity by promoting, in an energy-dependent manner, the assembly of the TTT complex composed of TELO2, TTI1 and TTI2 and the RUVBL complex composed of RUVBL1 and RUVBL2 into the TTT-RUVBL complex. This leads to the dimerization of the mTORC1 complex and its subsequent activation . May negatively regulate the ubiquitin proteasome pathway . . |
Accessions | ENST00000424454.5 ENST00000679428.1 [Q9BTA9-2] ENST00000375664.8 [Q9BTA9-2] A0A494C0C1 ENST00000354911.9 [Q9BTA9-1] A0A7P0TBE3 ENST00000679398.1 [Q9BTA9-2] ENST00000679570.1 ENST00000439676.5 [Q9BTA9-3] ENST00000375646.5 E9PMZ7 ENST00000628285.3 ENST00000442148.6 [Q9BTA9-2] ENST00000442148 C9JMU2 J3QT76 ENST00000651885.1 A0A9L9PXQ9 A0A8V8TQV5 ENST00000681112.1 ENST00000420266.6 ENST00000414108.6 ENST00000347934.8 [Q9BTA9-5] A0A0A0MRT2 J3QTA0 ENST00000651598.1 A0A7P0Z479 ENST00000428935.6 A0A8V8TR65 ENST00000680735.1 C9JVK6 A0A7P0T961 A0A0A0MSR1 ENST00000651441.1 A0A0D9SFY7 ENST00000526722.1 A0A494C0S5 ENST00000700325.1 ENST00000495268.3 A0A494C0B7 ENST00000706612.1 ENST00000448193.5 C9JD58 Q9BTA9 |